A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML

Guillermo Garcia-Manero; James McCloskey; Elizabeth A. Griffiths; Karen W.L. Yee; Amer M. Zeidan; Aref Al-Kali; H. Joachim Deeg; Mitchell Sabloff; Mary Margaret Keating; Nancy Zhu; Nashat Y. Gabrail; Salman Fazal; Joseph Maly; Olatoyosi Odenike; Amy E. DeZern; Casey L. O’Connell; Gail J. Roboz; Lambert Busque; Rena Buckstein; Harshad Amin; Brian Leber; Aditi Shastri; Aram Oganesian; Harold N. Keer; Mohammad Azab; Michael R. Savona

doi:10.1080/14796694.2025.2468578

A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML

Guillermo Garcia-Manero
, James McCloskey
, Elizabeth A. Griffiths
, Karen W.L. Yee
, Amer M. Zeidan
, Aref Al-Kali
, H. Joachim Deeg
, Mitchell Sabloff
, Mary Margaret Keating
, Nancy Zhu
, Nashat Y. Gabrail
, Salman Fazal
, Joseph Maly
, Olatoyosi Odenike
, Amy E. DeZern
, Casey L. O’Connell
, Gail J. Roboz
, Lambert Busque
, Rena Buckstein
, Harshad Amin

Brian Leber, Aditi Shastri, Aram Oganesian, Harold N. Keer, Mohammad Azab, Michael R. Savona

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	929-941
Number of pages	13
Journal	Future Oncology
Volume	21
Issue number	8
DOIs	https://doi.org/10.1080/14796694.2025.2468578
State	Published - 2025

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1080/14796694.2025.2468578

Cite this

Garcia-Manero, G., McCloskey, J., Griffiths, E. A., Yee, K. W. L., Zeidan, A. M., Al-Kali, A., Deeg, H. J., Sabloff, M., Keating, M. M., Zhu, N., Gabrail, N. Y., Fazal, S., Maly, J., Odenike, O., DeZern, A. E., O’Connell, C. L., Roboz, G. J., Busque, L., Buckstein, R., ... Savona, M. R. (2025). A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML. Future Oncology, 21(8), 929-941. https://doi.org/10.1080/14796694.2025.2468578

Garcia-Manero, G, McCloskey, J, Griffiths, EA, Yee, KWL, Zeidan, AM, Al-Kali, A, Deeg, HJ, Sabloff, M, Keating, MM, Zhu, N, Gabrail, NY, Fazal, S, Maly, J, Odenike, O, DeZern, AE, O’Connell, CL, Roboz, GJ, Busque, L, Buckstein, R, Amin, H, Leber, B, Shastri, A, Oganesian, A, Keer, HN, Azab, M & Savona, MR 2025, 'A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML', Future Oncology, vol. 21, no. 8, pp. 929-941. https://doi.org/10.1080/14796694.2025.2468578

@article{3867629d28204981afe22920925bfffe,

title = "A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML",

author = "Guillermo Garcia-Manero and James McCloskey and Griffiths, \{Elizabeth A.\} and Yee, \{Karen W.L.\} and Zeidan, \{Amer M.\} and Aref Al-Kali and Deeg, \{H. Joachim\} and Mitchell Sabloff and Keating, \{Mary Margaret\} and Nancy Zhu and Gabrail, \{Nashat Y.\} and Salman Fazal and Joseph Maly and Olatoyosi Odenike and DeZern, \{Amy E.\} and O{\textquoteright}Connell, \{Casey L.\} and Roboz, \{Gail J.\} and Lambert Busque and Rena Buckstein and Harshad Amin and Brian Leber and Aditi Shastri and Aram Oganesian and Keer, \{Harold N.\} and Mohammad Azab and Savona, \{Michael R.\}",

year = "2025",

doi = "10.1080/14796694.2025.2468578",

language = "English (US)",

volume = "21",

pages = "929--941",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Taylor and Francis Ltd.",

number = "8",

}

TY - JOUR

T1 - A plain language summary of the ASCERTAIN trial

T2 - oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML

AU - Garcia-Manero, Guillermo

AU - McCloskey, James

AU - Griffiths, Elizabeth A.

AU - Yee, Karen W.L.

AU - Zeidan, Amer M.

AU - Al-Kali, Aref

AU - Deeg, H. Joachim

AU - Sabloff, Mitchell

AU - Keating, Mary Margaret

AU - Zhu, Nancy

AU - Gabrail, Nashat Y.

AU - Fazal, Salman

AU - Maly, Joseph

AU - Odenike, Olatoyosi

AU - DeZern, Amy E.

AU - O’Connell, Casey L.

AU - Roboz, Gail J.

AU - Busque, Lambert

AU - Buckstein, Rena

AU - Amin, Harshad

AU - Leber, Brian

AU - Shastri, Aditi

AU - Oganesian, Aram

AU - Keer, Harold N.

AU - Azab, Mohammad

AU - Savona, Michael R.

PY - 2025

Y1 - 2025

UR - https://www.scopus.com/pages/publications/105000429821

UR - https://www.scopus.com/pages/publications/105000429821#tab=citedBy

U2 - 10.1080/14796694.2025.2468578

DO - 10.1080/14796694.2025.2468578

M3 - Article

C2 - 40051275

AN - SCOPUS:105000429821

SN - 1479-6694

VL - 21

SP - 929

EP - 941

JO - Future Oncology

JF - Future Oncology

IS - 8

ER -

A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this